The Pharmacopoeial Discussion Group (PDG) held its annual autumn meeting from 3 to 4 October 2023. The group welcomed the Indian Pharmacopoeia Commission (IPC) as a new member during the meeting (link). The addition of the IPC, a first in the over 34-year history of the PDG, facilitates the reach and enhances the impact of pharmacopoeial standards harmonisation. The PDG now includes the IPC, along with the European Pharmacopoeia (Ph. Eur.), the Japanese Pharmacopoeia (JP) and the United States Pharmacopeia (USP). The World Health Organization (WHO) continues as an observer. The USP hosted the meeting in Hyderabad, India which was the first PDG meeting held outside of the United States, Europe, or Japan as well as the first face-to-face format since 2019 due to the COVID-19 pandemic. A PDG stakeholder event also took place on 5 October 2023